Literature DB >> 1470047

Can we improve compliance with long-term HRT?

J Coope1, J Marsh.   

Abstract

In order to increase awareness of strategies to prevent osteoporosis and heart disease we designed a clinic offering education and screening to all women aged 40-60 years on our practice list of 8600 patients, starting in January 1988. Screening and supervision of HRT users occurred at a weekly clinic run by the doctor and nurse. Audit in August 1991 showed that there were 260 present users of HRT (20%) of our population of 1322 women aged 40-60 years. Seventy-eight percent had taken HRT for over a year and 15% for more than 5 years. Ex-users totalled 117, of whom 52% had taken HRT for over a year and 14% for over 5 years. Examination of the clinic registers and responses to postal questionnaires showed that 681 (51.5%) of patients attended the health education clinic. Of the clinic attenders, 25% took HRT compared with 10.8% of non-attenders. Compliance with long-term therapy measured by audit of repeat prescriptions varied between 84% and 92% over a period of 5 years. Reasons for stopping treatment were anxiety over possible side-effects, especially breast cancer and dislike of bleeding.

Entities:  

Mesh:

Year:  1992        PMID: 1470047     DOI: 10.1016/0378-5122(92)90249-4

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  6 in total

1.  Predictors of compliance with a home-based exercise program added to usual medical care in preventing postmenopausal osteoporosis: an 18-month prospective study.

Authors:  M A Mayoux-Benhamou; C Roux; A Perraud; J Fermanian; H Rahali-Kachlouf; M Revel
Journal:  Osteoporos Int       Date:  2004-07-29       Impact factor: 4.507

2.  Hormone replacement therapy.

Authors:  P J Roberts
Journal:  Br J Gen Pract       Date:  1995-10       Impact factor: 5.386

3.  Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

Authors:  M T Connelly; M Richardson; R Platt
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

4.  Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy.

Authors:  F Griffiths; B Convery
Journal:  Br J Gen Pract       Date:  1995-07       Impact factor: 5.386

5.  Utilisation of hormone replacement therapy by women doctors.

Authors:  A J Isaacs; A R Britton; K McPherson
Journal:  BMJ       Date:  1995-11-25

6.  The effect of low-dose combined hormone therapy (oestradiol and norethindrone acetate) on serum C-reactive protein levels and life quality in natural menopause women.

Authors:  Servin Gocer; Suleyman Guven; Hidayet Sal; Emine Seda Guvendag Guven
Journal:  Prz Menopauzalny       Date:  2021-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.